Penn Medicine Provider
Pathology and Laboratory Medicine
Charuhas Deshpande, MD
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP

About me

  • Associate Professor of Clinical Pathology and Laboratory Medicine

My areas of clinical expertise:

Pulmonary and Mediastinal Pathology,

Cardiovascular Pathology,

Genitourinary Pathology

Education and training

  • Medical School: University of Mumbai (formerly Bombay)
  • Residency: K B Bhabha Municipal Hospital
  • Residency: Seth G.S. Medical College
  • Residency: Tata Memorial Hospital
  • Residency: The Children's Hospital at OU Medical Center
  • Residency: Northwestern Memorial Hospital
  • Fellowship: Tata Memorial Hospital
  • Fellowship: Memorial Sloan-Kettering Cancer Center

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Deshpande is a Penn Medicine physician.

Qualifications and experience

My research

Clifford W Sandlin, Song Gu, Jun Xu, Charuhas Deshpande, Michael D Feldman, Matthew C Good Epithelial cell size dysregulation in human lung adenocarcinoma , PLoS One, 17(10): 2022


Abdeen S, Bdeir K, Abu-Fanne R, Maraga E, Higazi M, Khurram N, Feldman M, Deshpande C, Litzky LA, Heyman SN, Montone KT, Cines DB, Higazi AA. Alpha-defensins: risk factor for thrombosis in COVID-19 infection. , British Journal of Haematology, 194(1): 2021,44-52


Bryski MG, Frenzel-Sulyok LG, Delikatny EJ, Deshpande C, Litzky LA, Singhal S. Molecular imaging can identify the location to perform a frozen biopsy during intraoperative frozen section consultation. , PLoS One, 16(6): 2021,e0252731


Predina JD, Haas AR, Martinez M, O'Brien S, Moon EK, Woodruff P, Stadanlick J, Corbett C, Frenzel-Sulyok L, Bryski MG, Eruslanov E, Deshpande C, Langer C, Aguilar LK, Guzik BW, Manzanera AG, Aguilar-Cordova E, Singhal S, Albelda SM. Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic Activity , Molecular Therapy, 29(2): 2021,658-670


Thompson JC, Davis C, Deshpande C, Hwang WT, Jeffries S, Huang A, Mitchell TC, Langer CJ, Albelda SM. Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma , J Immunother Cancer., 8(2): 2020,e000974


Bauml JM, Mick R, Ciunci C, Aggarwal C, Davis C, Evans T, Deshpande C, Miller L, Patel P, Alley E, Knepley C, Mutale F, Cohen RB, Langer CJ. Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial. , JAMA Oncology, 1(2): 2019,1283-1290


Walter DM, Yates TJ, Ruiz-Torres M, Kim-Kiselak C, Gudiel AA, Deshpande C, Wang WZ, Cicchini M, Stokes KL, Tobias JW, Buza E, Feldser DM. RB constrains lineage fidelity and multiple stages of tumour progression and metastasis. , Nature, 569(7756): 2019,423-427


Predina JD, Keating J, Newton A, Corbett C, Xia L, Shin M, Frenzel Sulyok L, Deshpande C, Litzky L, Nie S, Kucharczuk JC, Singhal S. A clinical trial of intraoperative near-infrared imaging to assess tumor extent and identify residual disease during anterior mediastinal tumor resection. , Cancer, 125(5): 2019,807-817


Predina JD, Newton A, Corbett C, Xia L, Sulyok LF, Shin M, Deshpande C, Litzky L, Barbosa E, Low PS, Kucharczuk JC, Singhal S Localization of Pulmonary Ground-Glass Opacities with Folate Receptor-Targeted Intraoperative Molecular Imaging. , J Thorac Oncol., 13(7): 2018,1028-1036


Predina JD, Newton AD, Xia L, Corbett C, Connolly C, Shin M, Sulyok LF, Litzky L, Deshpande C, Nie S, Kularatne SA, Low PS, Singhal S. An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas. , Oncotarget, 9(17): 2018,13517-13529